Bruker Cellular Analysis has acquired 1 company of its own, including 1 in the last 5 years.
Bruker Cellular Analysis’ largest acquisition to date was in 2022, when it acquired IsoPlexis for $58M. Bruker Cellular Analysis has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
5858 Horton Street Suite 320,
EmeryVille, California
94608
United States,
(510) 858-2855
www.brukercellularanalysis.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2022-12-21 |
IsoPlexis · Life Science
Branford, Connecticut · www.isoplexis.com IsoPlexis is a life sciences company developing a diagnostic platform that identifies a wide range of patient immune responses at the cellular level. Its platform can assess safety and efficacy of therapeutics and monitor disease progression, enabling improved therapeutic development and informing physician decisions. IsoPlexis was founded in 2013 and is based in Branford, Connecticut. Advisors: Cravath, Swaine & Moore , Evercore Group |
58 | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
